Cantor Fitzgerald Forecasts Pfizer FY2026 Earnings
Pfizer Inc. (NYSE:PFE – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Pfizer in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst C. Gould anticipates that the biopharmaceutical company will post earnings per share of $3.10 for the year. […]
